Companies / United Kingdom
Drugmakers Call For Greater Uptake Of New Medicines
November 2006 | Product LaunchThe Association of the British Pharmaceutical Industry (ABPI) has asked the UK National Health Service (NHS) to accelerate its uptake of innovative medicines, citing statistics that show the benefits that new drugs bring to patients. However, BMI believes that the NHS and its cost-effectiveness regulator NICE will continue to delay the introduction of these products in order to save money.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.




